Lars Jacobsson Selected Research

Lars Jacobsson Research Topics

24	Neoplasms (Cancer) 01/2024 - 05/2002
16	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2003
5	Ascites 12/2017 - 11/2005
3	Carcinoma (Carcinomatosis) 08/2013 - 10/2007
2	Ovarian Epithelial Carcinoma 01/2023 - 01/2019
2	Neoplasm Micrometastasis 08/2013 - 09/2003
2	Schizophrenia (Dementia Praecox) 06/2013 - 04/2012
1	Intestinal Perforation 01/2019
1	Fatigue 01/2019
1	Body Weight (Weight, Body) 12/2017
1	Residual Neoplasm 11/2015
1	Tardive Dyskinesia 02/2015
1	Disease Progression 03/2013

9	Monoclonal AntibodiesIBA 01/2019 - 03/2003
6	211At-labeled monoclonal antibody MX35IBA 01/2021 - 08/2006
3	AntibodiesIBA 01/2021 - 09/2003
3	Radioisotopes (Radionuclides)IBA 01/2018 - 06/2003
3	Antipsychotic Agents (Antipsychotics)IBA 02/2015 - 04/2012
2	Astatine-211IBA 01/2021 - 10/2007
2	EpitopesIBA 01/2015 - 09/2003
2	Immunoconjugates (Immunoconjugate)IBA 08/2013 - 12/2005
2	Lysine (L-Lysine)FDA Link 12/2011 - 05/2002
2	AstatineIBA 12/2009 - 09/2003
1	SolutionsIBA 01/2024
1	Contrast MediaIBA 01/2023
1	Colloids (Colloid)IBA 01/2023
1	Thorium Dioxide (Thorotrast)IBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2021
1	farletuzumabIBA 01/2021
1	AntigensIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 08/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2013
1	procaine isothiocyanate (PRIT)IBA 03/2013
1	AvidinIBA 12/2011
1	Dihydrotachysterol (AT 10)IBA 10/2010
1	Trastuzumab (Herceptin)FDA Link 10/2007
1	poly-d-lysineIBA 09/2003
1	Biotin (Vitamin H)FDA Link 09/2003
1	SuspensionsIBA 03/2003

13	Radioimmunotherapy 01/2023 - 09/2003
12	Therapeutics 01/2023 - 05/2002
4	Drug Therapy (Chemotherapy) 01/2023 - 07/2009
4	Aftercare (After-Treatment) 12/2017 - 11/2005
2	Catheters 01/2019 - 07/2009
1	Intravenous Injections 01/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 08/2013
1	Radiotherapy 10/2010